NO992090L - Aktivt proteinkonjugat fra pinnsvin samt fremgangsmåte for fremstilling og anvendelse derav - Google Patents

Aktivt proteinkonjugat fra pinnsvin samt fremgangsmåte for fremstilling og anvendelse derav

Info

Publication number
NO992090L
NO992090L NO992090A NO992090A NO992090L NO 992090 L NO992090 L NO 992090L NO 992090 A NO992090 A NO 992090A NO 992090 A NO992090 A NO 992090A NO 992090 L NO992090 L NO 992090L
Authority
NO
Norway
Prior art keywords
preparation
hydrophobic
protein conjugate
amino acids
porcine protein
Prior art date
Application number
NO992090A
Other languages
English (en)
Norwegian (no)
Other versions
NO992090D0 (no
Inventor
Angelika Esswein
Kurt Lang
Petra Rueger
Tilmann Seytter
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP98107911A external-priority patent/EP0953575A1/de
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Publication of NO992090D0 publication Critical patent/NO992090D0/no
Publication of NO992090L publication Critical patent/NO992090L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2/00—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Zoology (AREA)
  • Neurology (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO992090A 1998-04-30 1999-04-29 Aktivt proteinkonjugat fra pinnsvin samt fremgangsmåte for fremstilling og anvendelse derav NO992090L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98107911A EP0953575A1 (de) 1998-04-30 1998-04-30 Aktives Hedgehog-Protein-Konjugat, Verfahren zur Herstellung und Verwendung
EP98116733 1998-09-03

Publications (2)

Publication Number Publication Date
NO992090D0 NO992090D0 (no) 1999-04-29
NO992090L true NO992090L (no) 1999-11-01

Family

ID=26149214

Family Applications (1)

Application Number Title Priority Date Filing Date
NO992090A NO992090L (no) 1998-04-30 1999-04-29 Aktivt proteinkonjugat fra pinnsvin samt fremgangsmåte for fremstilling og anvendelse derav

Country Status (18)

Country Link
US (4) US6468978B1 (de)
EP (2) EP0953576B1 (de)
JP (1) JP3433136B2 (de)
KR (1) KR19990083621A (de)
CN (1) CN1233616A (de)
AT (1) ATE308563T1 (de)
AU (1) AU719797B2 (de)
CA (1) CA2269221A1 (de)
CY (1) CY1105683T1 (de)
DE (1) DE69928040T2 (de)
DK (1) DK0953576T3 (de)
ES (1) ES2252886T3 (de)
HU (1) HUP9901411A2 (de)
IL (1) IL129620A (de)
MA (1) MA26625A1 (de)
NO (1) NO992090L (de)
NZ (1) NZ335385A (de)
SG (1) SG80028A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1034269A1 (de) * 1997-11-28 2000-09-13 Roche Diagnostics GmbH Aktive hedgehog-protein-mutante, verfahren zur herstellung und verwendung als arzneimittel
US6897297B1 (en) * 1997-12-03 2005-05-24 Curis, Inc. Hydrophobically-modified protein compositions and methods
DE69928040T2 (de) * 1998-04-30 2006-07-27 Curis, Inc., Cambridge Aktives Hedgehog-Protein-Konjugat, Verfahren zur Herstellung und Verwendung
ES2253851T3 (es) * 1998-08-07 2006-06-01 Curis, Inc. Composicion farmaceutica estable de proteinas hedgehog y uso de la misma.
TW570805B (en) * 1998-09-01 2004-01-11 Hoffmann La Roche Water-soluble pharmaceutical composition in an ionic complex
WO2000035948A1 (en) * 1998-12-03 2000-06-22 Biogen, Inc. Methods and compositions for treating disorders involving excitotoxicity
EP1025861A1 (de) * 1999-02-04 2000-08-09 Roche Diagnostics GmbH Pharmazeutische Zusammensetzung von hydrophob modifizierten Hedgehog-Proteinen und deren Verwendung
AU782493B2 (en) * 1999-06-01 2005-08-04 Curis, Inc. Polymer conjugates of hedgehog proteins and uses
US7052514B2 (en) * 2000-04-28 2006-05-30 Curis, Inc. Methods and reagents for tissue engineering of cartilage in vitro
US7573637B2 (en) * 2004-08-03 2009-08-11 Seiko Epson Corporation Intrinsic polarizer and method of manufacturing an intrinsic polarizer
US8669418B2 (en) * 2005-12-22 2014-03-11 Vib Vzw Means and methods for mediating protein interference
WO2009108868A2 (en) * 2008-02-27 2009-09-03 Radiomedix Inc. Radiolabeled hedgehog derivatives for imaging and therapy
US20100172889A1 (en) * 2008-12-05 2010-07-08 Catchmark Jeffrey M Degradable biomolecule compositions
WO2011047047A2 (en) * 2009-10-13 2011-04-21 The Penn State Research Foundation Composites containing polypeptides attached to polysaccharides and molecules
TW201542231A (zh) * 2011-06-06 2015-11-16 Kineta One Llc 以shk為主之醫藥組合物及其製備方法及用途
EP3024887B1 (de) 2013-07-26 2023-11-22 The Penn State Research Foundation Verfahren zur herstellung von polymerzusammensetzungen und beschichtungen damit
US20180360973A1 (en) * 2015-12-02 2018-12-20 Hanmi Pharm. Co., Ltd. Protein conjugate using a fatty acid derivative and method for preparation thereof
CN113167782B (zh) * 2018-10-30 2025-07-11 私募蛋白质体操作有限公司 用于样品质量评估的方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5364839A (en) * 1990-06-18 1994-11-15 Genetics Institute, Inc. Osteoinductive pharmaceutical formulations
WO1992009697A1 (en) * 1990-11-30 1992-06-11 Celtrix Laboratories, Inc. USE OF A BONE MORPHOGENETIC PROTEIN IN SYNERGISTIC COMBINATION WITH TGF-β FOR BONE REPAIR
US5789543A (en) * 1993-12-30 1998-08-04 President And Fellows Of Harvard College Vertebrate embryonic pattern-inducing proteins and uses related thereto
NZ278765A (en) * 1993-12-30 1998-05-27 Harvard College Vertebrate proteins involved in spatial arrangements of differentiated tissues called hedgehog proteins, their production and use
US6281332B1 (en) * 1994-12-02 2001-08-28 The Johns Hopkins University School Of Medicine Hedgehog-derived polypeptides
US5700774A (en) * 1996-03-26 1997-12-23 Genetics Institute, Inc. Compositions comprising bone morphogenic proteins and truncated parathyroid hormone related peptide, and methods of inducing cartilage by administration of same
GB9614871D0 (en) 1996-07-15 1996-09-04 Smithkline Beecham Plc Compounds
EP0966478A4 (de) * 1996-10-07 2002-08-21 Univ Johns Hopkins Med Neue vom igel abstammende polypeptide
EP1034269A1 (de) * 1997-11-28 2000-09-13 Roche Diagnostics GmbH Aktive hedgehog-protein-mutante, verfahren zur herstellung und verwendung als arzneimittel
EA003739B1 (ru) * 1997-12-03 2003-08-28 Байоджен, Инк. Гидрофобно-модифицированные белки, способы их получения и их применение
US6897297B1 (en) * 1997-12-03 2005-05-24 Curis, Inc. Hydrophobically-modified protein compositions and methods
DE69928040T2 (de) * 1998-04-30 2006-07-27 Curis, Inc., Cambridge Aktives Hedgehog-Protein-Konjugat, Verfahren zur Herstellung und Verwendung
ES2253851T3 (es) * 1998-08-07 2006-06-01 Curis, Inc. Composicion farmaceutica estable de proteinas hedgehog y uso de la misma.
US7052514B2 (en) * 2000-04-28 2006-05-30 Curis, Inc. Methods and reagents for tissue engineering of cartilage in vitro

Also Published As

Publication number Publication date
NO992090D0 (no) 1999-04-29
DK0953576T3 (da) 2006-03-20
US20070191274A1 (en) 2007-08-16
US7153836B2 (en) 2006-12-26
US6468978B1 (en) 2002-10-22
KR19990083621A (ko) 1999-11-25
JP2000053699A (ja) 2000-02-22
IL129620A0 (en) 2000-02-29
MA26625A1 (fr) 2004-12-20
CN1233616A (zh) 1999-11-03
HUP9901411A2 (hu) 1999-12-28
EP0953576A1 (de) 1999-11-03
US6818623B2 (en) 2004-11-16
AU2500999A (en) 1999-11-11
DE69928040T2 (de) 2006-07-27
AU719797B2 (en) 2000-05-18
IL129620A (en) 2009-06-15
EP1557427A3 (de) 2005-10-19
CY1105683T1 (el) 2010-12-22
NZ335385A (en) 2000-09-29
DE69928040D1 (de) 2005-12-08
US20030139574A1 (en) 2003-07-24
SG80028A1 (en) 2001-04-17
ATE308563T1 (de) 2005-11-15
HU9901411D0 (en) 1999-07-28
EP1557427A2 (de) 2005-07-27
ES2252886T3 (es) 2006-05-16
US20050148510A1 (en) 2005-07-07
CA2269221A1 (en) 1999-10-30
JP3433136B2 (ja) 2003-08-04
EP0953576B1 (de) 2005-11-02

Similar Documents

Publication Publication Date Title
Balhorn et al. Mouse sperm chromatin proteins: quantitative isolation and partial characterization
AU2022201708A1 (en) Compounds and methods for inhibiting phosphate transport
Dolphin et al. Pertussis toxin reverses adenosine inhibition of neuronal glutamate release
Hu et al. An angiogenin-binding protein from endothelial cells.
Segui‐Real et al. Functional independence of the protein translocation machineries in mitochondrial outer and inner membranes: passage of preproteins through the intermembrane space.
PT835262E (pt) Metodo para o tratamento de osteopenia induzida por corticosteroides
EP0748817A3 (de) Parathyroidhormonderivaten und deren Verwendung
ES2028493A6 (es) Un metodo para preparar una composicion destinada a inhibir la proliferacion virica:
CY1105683T1 (el) Ενεργο συζυγες ακανθοχοιρικης πρωτεϊνης, μεθοδος για την παρασκευη και χρηση αυτου
DE69831500D1 (de) Humane checkpointkinase, hcds1, zusammensetzungen und verfahren
Saks et al. Specific inhibition of ATP-ADP translocase in cardiac mitoplasts by antibodies against mitochondrial creatine kinase
Propst et al. Opioids, noradrenaline and GTP analogs inhibit cholera toxin activated adenylate cyclase in neuroblastoma× glioma hybrid cells
Jensen et al. Structure-function studies of N-acyl derivatives of tryptophan that function as specific cholecystokinin receptor antagonists
von Stedingk et al. Mitochondrial protein import: modification of sulfhydryl groups of the inner mitochondrial membrane import machinery in Solanum tuberosum inhibits protein import
Forte et al. Studies of kidney plasma membrane adenosine-3′, 5′-monophosphate-dependent protein kinase
Tait et al. Artificial low‐molecular‐mass substrates of cholera toxin
DK292584A (da) Biologisk aktive konjugater, deres fremstilling og anvendelse
DE10080849D2 (de) Fragmente des Virus Proteins 2 oder 3 des Polymavirus als Fähren für Wirkstoffe
PE20001068A1 (es) Produccion de analogos de tripsinogeno recombinante solubles
Meiniel et al. The complex-type glycoprotein secreted by the bovine subcommissural organ: an immunological study using C1B8A8 monoclonal antibody
Elhammer et al. Glycosylation of rat liver cytochrome b5 on the ribosomal level
ATE358171T1 (de) Hydrophobe aminosäuren enthaltende trockene zusammensetzung
Pines et al. Modulation of responsiveness of the adenylate cyclase system in avian chondroprogenitor cells by pertussis toxin, PTH, and PGE2
AR020069A1 (es) Conjugado de proteina erizo, proceso para su preparacion, composicion farmaceutica que lo contiene, procedimiento para su preparacion, proteina erizo y suempleo para la obtencion de dicho conjugado
COLI Bernard N. Violand, Ned R. Siegel, Gregg Bogosian, Wesley E. Workman and James F. Kane Monsanto Agricultural Co., Animal Sciences Division

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application